Tevogen Inc. Active Patents
3 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2021-05-07: Application 17314154; Invention COVID-19 PEPTIDE SPECIFIC T-CELLS AND METHODS OF TREATING AND PREVENTING COVID-19; Applicant Tevogen Bio Inc.; Status Patented Case.
- 2021-05-07: Application 17314152; Invention COVID-19 PEPTIDE SPECIFIC T-CELLS AND METHODS OF TREATING AND PREVENTING COVID-19; Applicant Tevogen Bio Inc.; Status Patented Case.
- 2020-12-09: Application 17116227; Invention COVID-19 PEPTIDE SPECIFIC T-CELLS AND METHODS OF TREATING AND PREVENTING COVID-19; Applicant Tevogen Bio Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-05-07 | 17314154 | COVID-19 PEPTIDE SPECIFIC T-CELLS AND METHODS OF TREATING AND PREVENTING COVID-19 | Tevogen Bio Inc. | Patented Case | 2021-12-28 | 11207401 | Ryan SAADI | United States | FOLEY, SHANON A | |
| 2021-05-07 | 17314152 | COVID-19 PEPTIDE SPECIFIC T-CELLS AND METHODS OF TREATING AND PREVENTING COVID-19 | Tevogen Bio Inc. | Patented Case | 2022-01-11 | 11219684 | Ryan SAADI | United States | KELLY, ROBERT M | |
| 2020-12-09 | 17116227 | COVID-19 PEPTIDE SPECIFIC T-CELLS AND METHODS OF TREATING AND PREVENTING COVID-19 | Tevogen Bio Inc. | Patented Case | 2021-12-07 | 11191827 | Ryan SAADI | United States | FOLEY, SHANON A |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B |